What is NDC 83047-410?

83047-410 is the product NDC for Aucatzyl (obecabtagene autoleucel) kit, listed with the FDA by Autolus Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Aucatzyl (Obecabtagene autoleucel).

Autolus Inc., NDC labeler code 83047. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Aucatzyl?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Aucatzyl NDC 83047-410 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)83047-410Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83047-0410Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83047-410-04	83047041004	1 KIT in 1 PACKAGE (83047-410-04) * 1 SUSPENSION in 1 BAG (83047-100-30) * 1 SUSPENSION in 1 BAG (83047-100-10) * 1 SUSPENSION in 1 BAG (83047-300-30) * 1 SUSPENSION in 1 BAG (83047-010-10)Marketed from Nov 8, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aucatzyl
Generic name (nonproprietary): obecabtagene autoleucel
Dosage form: Kit
Labeler: Autolus Inc.NDC labeler code 83047
Product type: Cellular therapy
Marketing category: BLA — Biologics License ApplicationApplication BLA 125813
Marketing start: Nov 8, 2024
Listing expires: Dec 31, 2027
Identifiers: Product ID 83047-410_5ff8c7fb-5a15-4817-bd53-ae3ea48d8449SPL ID 5ff8c7fb-5a15-4817-bd53-ae3ea48d8449SPL set ID 4fef6986-b988-45e4-8c20-b14f0ef1f538RxCUI 2700168, 2700173, 2700174, 2700175

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N483047041004 followed by a unit qualifier and the quantity

Package 83047-0410-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 23, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

1 INDICATION AND USAGE AUCATZYL is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). AUCATZYL is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 83047-410

What is NDC 83047-410?: 83047-410 is the product NDC for Aucatzyl (obecabtagene autoleucel) kit, listed with the FDA by Autolus Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Aucatzyl (Obecabtagene autoleucel).
Who is the labeler?: Autolus Inc., NDC labeler code 83047. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Aucatzyl?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Aucatzyl (Obecabtagene autoleucel) NDC 83047-410